C
Citius Oncology, Inc. (CTOR)
NCM – Real Time Price. Currency in USD
0.62
-0.04 (-6.06%)
At close: Jun 26, 2026, 4:00 PM EDT
0.64
+0.02 (3.71%)
After-hours: Jun 26, 2026, 5:34 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.62
-0.04 (-6.06%)
At close: Jun 26, 2026, 4:00 PM EDT
0.64
+0.02 (3.71%)
After-hours: Jun 26, 2026, 5:34 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Total debt $3.8M significantly exceeds cash reserves ($2.6M), raising financial stability concerns
Total current liabilities $58.8M surpass Total current assets $29.4M, signaling liquidity issues
Debt-to-equity ratio (0.1) is well below the industry average (-0.8), showcasing prudent financial management
Interest coverage ratio (-866.3x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$4.0M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.50 | 2.52 | 4.0 | |
| Quick ratio | 0.12 | 1.78 | 2.0 | |
| Debt to Equity | 0.11 | -0.80 | 9.0 | |
| Debt to Assets | 0.04 | 0.73 | 9.0 | |
| Interest coverage | -866.26 | -13.90 | 1.0 | |
| Weighted average score | 5.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | 6M |
| Gross Profit | N/A | N/A | N/A | N/A | 3M |
| Operating Income | -138K | -1M | -21M | -24M | -44M |
| Net Income | 381K | 2M | -21M | -25M | -43M |
| EBITDA | -138K | -1M | -21M | -24M | -42M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 50 | 5.5 |
| Next quarter | N/A | -166.67 | 1.0 |
| Current year | N/A | -52.94 | 1.0 |
| Next year | 356.95 | 119.23 | 10 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -57.72 | -380.82 | -349.99 | 46.05 | 3.3 |
| Y/Y | 999 | -243.98 | -145.44 | N/A | 3.3 |
| 3y average | 999 | -151.97 | N/A | -1826.38 | 3.3 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 2.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |